Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Covalon Technologies Ltd (TSE:COV)
TSXV:COV
RESEARCH TOOLSreports
Holding TSE:COV?
Track your performance easily
COV Stock Chart & Stats
Day’s RangeC$0 - C$0
52-Week RangeC$0.95 - C$3.31
Previous CloseC$3.25
Volume35.98K
Average Volume (3M)28.66K
Market Cap
C$84.95M
Enterprise ValueC$78.94M
Total Cash (Recent Filing)C$7.26M
Total Debt (Recent Filing)C$1.26M
Price to Earnings (P/E)―
Beta0.21
Next Earnings
Jan 23, 2025EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.03
Shares Outstanding25,067,677
10 Day Avg. Volume38,024
30 Day Avg. Volume28,664
Standard Deviation0.18
R-Squared0.03
Alpha0.02
Financial Highlights & Ratios
Price to Book (P/B)4.11
Price to Sales (P/S)3.10
Price to Cash Flow (P/CF)-20.60
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Covalon Technologies News
PremiumCompany Announcements
Covalon Showcases Pediatric Vascular Innovations at APHON
PremiumCompany Announcements
Covalon Technologies Soars with Q3 Financial Growth
PremiumCompany Announcements
Covalon Technologies to Unveil Q3 Financial ResultsPremiumCompany Announcements
Covalon Technologies: Strong Q2 Financial MomentumPremiumCompany Announcements
Covalon Technologies Q2 Financial Results RevealPremiumCompany Announcements
Covalon Showcases Innovative Medical Dressings
PremiumCompany Announcements
Covalon Shareholders Unanimously Back Board and Auditors
PremiumCompany Announcements
Covalon Announces Virtual Shareholders’ MeetingOptions Prices
Currently, No data available
---
Ownership Overview
59.66% Insiders
0.00% Mutual Funds
0.00% Other Institutional Investors
40.34% Public Companies and
Individual Investors
COV FAQ
What was Covalon Technologies Ltd’s price range in the past 12 months?
Covalon Technologies Ltd lowest stock price was C$0.95 and its highest was C$3.31 in the past 12 months.
What is Covalon Technologies Ltd’s market cap?
Currently, no data Available
When is Covalon Technologies Ltd’s upcoming earnings report date?
Covalon Technologies Ltd’s upcoming earnings report date is Jan 23, 2025 which is in 125 days.
How were Covalon Technologies Ltd’s earnings last quarter?
Covalon Technologies Ltd released its earnings results on Aug 21, 2024. The company reported C$0.059 earnings per share for the quarter, beating the consensus estimate of N/A by C$0.059.
Is Covalon Technologies Ltd overvalued?
According to Wall Street analysts Covalon Technologies Ltd’s price is currently Overvalued.
Does Covalon Technologies Ltd pay dividends?
Covalon Technologies Ltd does not currently pay dividends.
What is Covalon Technologies Ltd’s EPS estimate?
Covalon Technologies Ltd’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Covalon Technologies Ltd have?
Covalon Technologies Ltd has 26,138,151 shares outstanding.
What happened to Covalon Technologies Ltd’s price movement after its last earnings report?
Covalon Technologies Ltd reported an EPS of C$0.059 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went up 8.696%.
Which hedge fund is a major shareholder of Covalon Technologies Ltd?
Currently, no hedge funds are holding shares in TSE:COV
---
Covalon Technologies Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Positive
20 days / 200 days
Momentum
132.97%
12-Months-Change
Fundamentals
Return on Equity
-3.85%
Trailing 12-Months
Asset Growth
0.30%
Trailing 12-Months
Company Description
Covalon Technologies Ltd
Covalon Technologies Ltd is principally engaged in the business of developing, licensing, and selling medical technologies. The company develops advanced wound care line which is designed for the treatment of a wide range of wounds; and infection prevention products such as MediClear PreOp which is a breathable, transparent, self-adhesive silicone barrier film that conforms to the contours of the body. It also develops perioperative care products. The company generates its revenue through development contracts, licensing agreements, and distribution contracts and sales.
---
Technical Analysis
Constellation Software
―
VIQ Solutions
―
Microbix Biosystms
―
ProMIS Neurosciences
―
---